LONDON--(BUSINESS WIRE)-- The market for seasonal influenza vaccines is characterized by the presence of a large number of players operating on different geographical scales: global, regional and local. The increasing awareness, expansion of vaccination and growing support of official authorities globally fuel the market growth. The USA, Italy, the UK, France, Germany and Japan are amid the largest country markets for seasonal influenza vaccine.
In the USA, for instance, the market exceeded USD 1.55 billion in 2011 and is forecast to gain USD 0.6 billion by 2019. The German market, meantime, amounted to around USD 386 million in 2011. It is expected to be above USD 483 million in 2018.
New research report “Seasonal Influenza Vaccines Market in Top Seven Countries to 2018 - Next Generation Quadrivalent Vaccines to Dominate the Market by Offering Broader Protection via Single Dose” developed by GBI Research draws up an elaborate picture of the market for seasonal influenza vaccine in the key seven countries. The study provides access to valuable data on the vaccination coverage, price dynamics, market size and market drivers and challenges. Regulatory landscape overview, profiles of companies, M&A activities and future forecast can be found in the report.
Countries covered include: the USA, the UK, France, Italy, Spain, Germany and Japan.
Title: Seasonal Influenza Vaccines Market in Top Seven Countries to 2018 - Next Generation Quadrivalent Vaccines to Dominate the Market by Offering Broader Protection via Single Dose
Published: October, 2012
Price: US$ 3,500.00
More Other Insightful Research Reports by GBI Research are Available:
- Butadiene Europe and Middle East Market to 2020 - North American Supply Shortages to Drive European Exports
- Downstream Processing in Biopharmaceuticals - Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness
- E-waste Management Market to 2020 - Expansion of Domestic Electronics Sector to Drive Asia Pacific Growth Despite Ban on Illegal Exports from Developed Countries
- Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market
More new market research reports by GBI Research can be found at http://marketpublishers.com/members/gbiresearch/info.html